FiercePharma  Aug 11  Comment 
Takeda Pharmaceuticals' new French-born CEO knows he is seen as an outsider by many Japanese, including some of Takeda's alumni. He appreciates their concerns and says Takeda will remain a Japanese-based company, true to its heritage. But he also...
Japan Today  Aug 6  Comment 
Japan's biggest drugmaker Takeda Pharmaceutical Co will become more selective in its choice of research and development projects, its newly appointed president said, as the company struggles with shrinking margins due to a dearth of new...
FierceBiotech  Aug 5  Comment 
Christophe Weber, Takeda's anointed next CEO, sees a brighter future through specialization for the Japanese drugmaker, promising to focus only on therapeutic areas where it can lead, leaving behind losing programs.
SeekingAlpha  Aug 2  Comment 
Takeda Pharmaceutical Co., Ltd. (OTCPK:TKPHF) Q2 2014 Earnings Conference Call August 1, 2014 4:00 AM ET Executives Christopher Hohman – Senior Vice President-Corporate Communications Department Tsudoi Miyoshi – Senior Vice...
SeekingAlpha  Aug 1  Comment 
Takeda Pharmaceutical Co., Ltd (OTCPK:TKPYY) Q2 2014 Earnings Call August 01, 2014 5:00 AM ET Executives Tsudoi Miyoshi – Senior Vice President and Head, Chief Medical & Scientific Officer, Office François Roger – Chief...
FiercePharma  Jul 2  Comment 
Takeda's board swept aside concerns over having the company run by a non-Japanese executive, setting up Frenchman Christophe Weber to carry out the plans he believes are needed to turn around the faltering drugmaker.
FierceBiotech  Jul 2  Comment 
Christophe Weber is next in line for the throne at Takeda, and the former GlaxoSmithKline exec has a mind to grow the Japanese pharma through dealmaking, hoping to refill the in-transition company's pipeline and expand in emerging markets.
Wall Street Journal  Jun 27  Comment 
The chief executive of Takeda Pharmaceutical struck back against shareholders angry about his plan to appoint a foreigner as president, saying the move was necessary for global growth.
Wall Street Journal  Jun 26  Comment 
Ahead of the annual meeting of Takeda Pharmaceutical, a group of more than 100 shareholders and former employees have expressed their opposition to Takeda's plan to name a Frenchman as its next president.


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki